✦ LIBER ✦

Phase 1 and pharmacokinetic study of weekly docosahexaenoic acid-paclitaxel, Taxoprexin®, in resistant solid tumor malignancies

✍ Scribed by Paula M. Fracasso; Joel Picus; Jonathan D. Wildi; Sherry A. Goodner; Allison N. Creekmore; Feng Gao; Ramaswamy Govindan; Matthew J. Ellis; Benjamin R. Tan; Gerald P. Linette; ChauHwei J. Fu; Helen S. Pentikis; Stephen C. Zumbrun; Merrill J. Egorin; Robert E. Bellet

Publisher: Springer
Year: 2008
Tongue: English
Weight: 396 KB
Volume: 63
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-008-0756-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I and pharmacokinetic study of nab

Phase I and pharmacokinetic study of nab-paclitaxel, nanoparticle albumin-bound paclitaxel, administered weekly to Japanese patients with solid tumors and metastatic breast cancer

✍ Masashi Ando; Kan Yonemori; Noriyuki Katsumata; Chikako Shimizu; Taizo Hirata; H 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 361 KB

A Phase 1 study of UCN-01 in combination

A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies

✍ Paula M. Fracasso; Kerry J. Williams; Ronald C. Chen; Joel Picus; Cynthia X. Ma; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 451 KB

## Purpose UCN-01 (7-hydroxystaurosporine) is a multi-targeted protein kinase inhibitor that exhibits synergistic activity with DNA-damaging agents in preclinical studies. We conducted a Phase I study to determine the maximum-tolerated dose (MTD), dose-limiting toxicity (DLT), pharmacokinetic, and

A phase I and pharmacokinetic study of p

A phase I and pharmacokinetic study of paclitaxel poliglumex and cisplatin in patients with advanced solid tumors

✍ Claire F. Verschraegen; Keith Skubitz; Adil Daud; Andrzej P. Kudelka; Ian Rabino 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 310 KB

A phase I, pharmacokinetic and pharmacod

A phase I, pharmacokinetic and pharmacodynamic dose escalation trial of weekly paclitaxel with interferon-α2b in patients with solid tumors

✍ Bryan Schneider; Anna Fukunaga; Daryl Murry; Christy Yoder; Karen Fife; Anne Fos 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 334 KB

Phase I and pharmacokinetic study of mit

Phase I and pharmacokinetic study of mitomycin C and celecoxib as potential modulators of tumor resistance to irinotecan in patients with solid malignancies

✍ Y. Xu; J. M. Kolesar; L. J. Schaaf; R. Drengler; W. Duan; G. Otterson; C. Shapir 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 314 KB

A phase I escalating single-dose and wee

A phase I escalating single-dose and weekly fixed-dose study of cetuximab pharmacokinetics in Japanese patients with solid tumors

✍ Kuniaki Shirao; Takayuki Yoshino; Narikazu Boku; Ken Kato; Tetsuya Hamaguchi; Hi 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 342 KB